Microsatellite Instability - 23 Studies Found Not yet recruiting : Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer : Colorectal Adenocarcinoma High-Frequency Microsatellite Instability : 2016-12-19 : Drug: Atezolizumab Given IV Not yet recruiting : Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability : Colon Adenocarcinoma DNA Repair Disorder Lynch Syndrome : 2016-09-22 : Drug: Atezolizumab Given IV Recruiting : Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) : Colorectal Carcinoma : 2015-09-28 : Drug: mFOLFOX6 Regimen consist Not yet recruiting : Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer : Castration Levels of Testosterone Hormone-Resistant Prostate Cancer Biological: Durvalumab Given I Recruiting : A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer : MSI-L/MSS Stage II Colon Cancer : 2016-08-01 : Drug: tegafur-uracil Completed : Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status : Colorectal Cancer : 2009-05-28 : Drug: olaparib 400 mg po bid continuously Completed : Genetic Study of Young Patients With Colorectal Cancer : Colorectal Cancer : 2002-09-06 : Genetic: microsatellite instability analysis Recruiting : Tissue Microarrays (TMAs) Construction in Lung Cancer Samples : Lung Cancer : 2017-04-21 Recruiting : Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma : Metastatic Colorectal Adenocarcinoma : 2012-07-09 : Drug: Gemcitabine intravenous Recruiting : A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors : Solid Tumor Microsatellite Instability-High (MSI-H) Solid Tumor : 2016-06-01 : Drug: LY3300054 Administered I Next >>>